Sisto Perdonà

Summary

Country: Italy

Publications

  1. ncbi request reprint Role of dynamic sentinel node biopsy in penile cancer: our experience
    S Perdona
    Department of Urology, IRCCS, National Cancer Institute, G Pascale Foundation, Naples, Italy
    J Surg Oncol 93:181-5. 2006
  2. ncbi request reprint Renal cell carcinoma with solitary toe metastasis
    Sisto Perdonà
    Department of Urology, National Cancer Institute, I R C C S Fondazione G Pascale, Naples, Italy
    Int J Urol 12:401-4. 2005
  3. ncbi request reprint Efficacy of tamoxifen and radiotherapy for prevention and treatment of gynaecomastia and breast pain caused by bicalutamide in prostate cancer: a randomised controlled trial
    Sisto Perdonà
    Department of Urology, National Tumour Institute, G Pascale Foundation IRCSS, Naples, Italy
    Lancet Oncol 6:295-300. 2005
  4. doi request reprint Paclitaxel in pretreated metastatic penile cancer: final results of a phase 2 study
    Giuseppe Di Lorenzo
    Genitourinary Oncology and Rare Cancer Center, Federico II University, Naples, Italy
    Eur Urol 60:1280-4. 2011
  5. doi request reprint Cisplatin and 5-fluorouracil in inoperable, stage IV squamous cell carcinoma of the penis
    Giuseppe Di Lorenzo
    Genitourinary Cancer Section and Rare Cancer Center, University Federico II, Naples, Italy
    BJU Int 110:E661-6. 2012
  6. ncbi request reprint Dynamic sentinel node biopsy in clinically node-negative penile cancer versus radical inguinal lymphadenectomy: a comparative study
    Sisto Perdonà
    Department of Urology, National Cancer Institute, Naples, Italy
    Urology 66:1282-6. 2005
  7. doi request reprint Phase II trial of cisplatin plus prednisone in docetaxel-refractory castration-resistant prostate cancer patients
    Carlo Buonerba
    Department of Endocrinology and Medical Oncology, Genitourinary Cancer Section, University Federico II, Naples, Italy
    Cancer Chemother Pharmacol 67:1455-61. 2011
  8. doi request reprint Predicting prostate biopsy outcome: prostate health index (phi) and prostate cancer antigen 3 (PCA3) are useful biomarkers
    Matteo Ferro
    Department of Urology, University of Naples Federico II, Naples, Italy
    Clin Chim Acta 413:1274-8. 2012
  9. doi request reprint Combination of bevacizumab and docetaxel in docetaxel-pretreated hormone-refractory prostate cancer: a phase 2 study
    Giuseppe Di Lorenzo
    Department of Clinical and Molecular Oncology, Federico II University, Naples, Italy
    Eur Urol 54:1089-94. 2008
  10. ncbi request reprint Vesicourethral anastomosis during radical retropubic prostatectomy: does the number of sutures matter?
    Luigi Gallo
    Department of Urology, National Cancer Institute Pascale Foundation, Naples, Italy
    Urology 69:547-51. 2007

Collaborators

Detail Information

Publications21

  1. ncbi request reprint Role of dynamic sentinel node biopsy in penile cancer: our experience
    S Perdona
    Department of Urology, IRCCS, National Cancer Institute, G Pascale Foundation, Naples, Italy
    J Surg Oncol 93:181-5. 2006
    ..We report our initial experience with a relatively new technique, the so-called "dynamic sentinel node biopsy", in patients with penile cancer...
  2. ncbi request reprint Renal cell carcinoma with solitary toe metastasis
    Sisto Perdonà
    Department of Urology, National Cancer Institute, I R C C S Fondazione G Pascale, Naples, Italy
    Int J Urol 12:401-4. 2005
    ..Thus, metastatic RCC should be included in the differential diagnosis of all enlarging cutaneous nodules, wherever they develop...
  3. ncbi request reprint Efficacy of tamoxifen and radiotherapy for prevention and treatment of gynaecomastia and breast pain caused by bicalutamide in prostate cancer: a randomised controlled trial
    Sisto Perdonà
    Department of Urology, National Tumour Institute, G Pascale Foundation IRCSS, Naples, Italy
    Lancet Oncol 6:295-300. 2005
    ..We aimed to compare tamoxifen with radiotherapy for prevention and treatment of gynaecomastia, breast pain, or both during bicalutamide monotherapy for prostate cancer...
  4. doi request reprint Paclitaxel in pretreated metastatic penile cancer: final results of a phase 2 study
    Giuseppe Di Lorenzo
    Genitourinary Oncology and Rare Cancer Center, Federico II University, Naples, Italy
    Eur Urol 60:1280-4. 2011
    ..Previously published preliminary findings showed promising activity of paclitaxel in chemotherapy-pretreated metastatic penile cancer...
  5. doi request reprint Cisplatin and 5-fluorouracil in inoperable, stage IV squamous cell carcinoma of the penis
    Giuseppe Di Lorenzo
    Genitourinary Cancer Section and Rare Cancer Center, University Federico II, Naples, Italy
    BJU Int 110:E661-6. 2012
    ..Neutropenia was the most important grade 3-4 side effect observed, occurring in 20% of patients. These data provide confirmation that such a combination regimen is moderately effective and well tolerated in patients with SCCP...
  6. ncbi request reprint Dynamic sentinel node biopsy in clinically node-negative penile cancer versus radical inguinal lymphadenectomy: a comparative study
    Sisto Perdonà
    Department of Urology, National Cancer Institute, Naples, Italy
    Urology 66:1282-6. 2005
    ..To evaluate the reliability and morbidity of dynamic sentinel node biopsy compared with radical inguinal lymphadenectomy (RIL) in the treatment of selected patients with squamous cell penile carcinoma...
  7. doi request reprint Phase II trial of cisplatin plus prednisone in docetaxel-refractory castration-resistant prostate cancer patients
    Carlo Buonerba
    Department of Endocrinology and Medical Oncology, Genitourinary Cancer Section, University Federico II, Naples, Italy
    Cancer Chemother Pharmacol 67:1455-61. 2011
    ..Docetaxel represents the first-line treatment for castration-resistant prostate cancer (CRPC). New therapeutic options are needed for subsequent lines of therapy in CRPC patients...
  8. doi request reprint Predicting prostate biopsy outcome: prostate health index (phi) and prostate cancer antigen 3 (PCA3) are useful biomarkers
    Matteo Ferro
    Department of Urology, University of Naples Federico II, Naples, Italy
    Clin Chim Acta 413:1274-8. 2012
    ..In conclusion, %p2PSA, phi and PCA3 may predict a diagnosis of PCa in men undergoing their first prostate biopsy. PCA3 score is more useful in discriminating between HGPIN and non-cancer...
  9. doi request reprint Combination of bevacizumab and docetaxel in docetaxel-pretreated hormone-refractory prostate cancer: a phase 2 study
    Giuseppe Di Lorenzo
    Department of Clinical and Molecular Oncology, Federico II University, Naples, Italy
    Eur Urol 54:1089-94. 2008
    ..No agents are approved for second-line therapy in HRPC, but common standard practice for the oncologists is to treat patients also after docetaxel failure...
  10. ncbi request reprint Vesicourethral anastomosis during radical retropubic prostatectomy: does the number of sutures matter?
    Luigi Gallo
    Department of Urology, National Cancer Institute Pascale Foundation, Naples, Italy
    Urology 69:547-51. 2007
    ..To prospectively evaluate the outcome of radical retropubic prostatectomy using three different techniques of vesicourethral anastomosis (VUA), with a different number of sutures used during this surgical step...
  11. ncbi request reprint Quality of life in women with multiple sclerosis and overactive bladder syndrome
    Giuseppe Quarto
    Division of Urology, Second University of Naples, Naples, Italy
    Int Urogynecol J Pelvic Floor Dysfunct 18:189-94. 2007
    ..In conclusion, OAB symptoms have a major impact on the QoL in patients with MS, even if their perception of QoL impairment remains limited. Optimal management in these subjects should include a complete UDS assessment...
  12. pmc Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) significantly improve prostate cancer detection at initial biopsy in a total PSA range of 2-10 ng/ml
    Matteo Ferro
    Urology Unit, University Federico II, Naples, Italy
    PLoS ONE 8:e67687. 2013
    ..001 and p = 0.01, respectively). In conclusion, both phi and PCA3 comparably increase the accuracy in predicting the presence of PCa in total PSA range 2-10 ng/ml at initial biopsy, outperforming currently used %fPSA. ..
  13. ncbi request reprint Gyrus bipolar versus standard monopolar transurethral resection of the prostate: a randomized prospective trial
    Marco De Sio
    Department of Urology, Seconda Universita di Napoli, Naples, Italy
    Urology 67:69-72. 2006
    ..To compare bipolar plasmakinetic (PK) with standard monopolar transurethral resection of the prostate (TURP)...
  14. ncbi request reprint Bladder-sparing, combined-modality approach for muscle-invasive bladder cancer: a multi-institutional, long-term experience
    Sisto Perdonà
    Comprehensive Urology Unit, National Tumor Institute, G Pascale Foundation, Naples, Italy
    Cancer 112:75-83. 2008
    ..The authors evaluated their long-term experience with combined-modality, conservative treatment in patients with muscle-invasive bladder cancer...
  15. doi request reprint Combined magnetic resonance spectroscopy and dynamic contrast-enhanced imaging for prostate cancer detection
    Sisto Perdonà
    Urology Section, Istituto Nazionale Tumori, Fondazione G Pascale, Naples, Italy
    Urol Oncol 31:761-5. 2013
    ..The use of magnetic resonance spectroscopy imaging (MRSI) and dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) have emerged as a valid diagnostic tools for prostate cancer (CaP)...
  16. doi request reprint Chondroitin sulphate enhances the antitumor activity of gemcitabine and mitomycin-C in bladder cancer cells with different mechanisms
    Matteo Ferro
    Department of Urology, University Federico II, Naples, Italy
    Oncol Rep 27:409-15. 2012
    ..In conclusion, in the human bladder cancer cell line HT-1376 pharmacological combination of CS with GEM or MMC resulted in a strong synergism on cell growth inhibition...
  17. doi request reprint Gemcitabine versus bacille Calmette-Guérin after initial bacille Calmette-Guérin failure in non-muscle-invasive bladder cancer: a multicenter prospective randomized trial
    Giuseppe Di Lorenzo
    Department of Molecular and Clinical Endocrinology and Oncology, Federico II University, Naples, Italy
    Cancer 116:1893-900. 2010
    ..The efficacy of intravesical gemcitabine was evaluated compared with repeated administration of bacille Calmette-Guérin (BCG) after BCG failure in high-risk, non-muscle-invasive bladder cancer (BC)...
  18. doi request reprint Activity and toxicity of paclitaxel in pretreated metastatic penile cancer patients
    Giuseppe Di Lorenzo
    University Federico II, Naples, Italy
    Anticancer Drugs 20:277-80. 2009
    ..Paclitaxel is well tolerated and associated with promising efficacy. Further trials, also in a neoadjuvant setting, are needed to corroborate our preliminary findings...
  19. doi request reprint The role of short frenulum and the effects of frenulectomy on premature ejaculation
    Luigi Gallo
    Studio Urologico Gallo, Department of Andrology, Naples, Italy
    J Sex Med 7:1269-76. 2010
    ..The role of short frenulum and the effects of frenulectomy on premature ejaculation (PE) were never investigated...
  20. ncbi request reprint Management of gynaecomastia in patients with prostate cancer: a systematic review
    Giuseppe Di Lorenzo
    Department of Endocrinology and Molecular and Clinical Oncology, Second University Naples, Naples, Italy
    Lancet Oncol 6:972-9. 2005
    ..In this review, management options for gynaecomastia caused by hormonal manipulation in patients with prostate cancer are discussed...
  21. ncbi request reprint The use of tamsulosin in the medical treatment of ureteral calculi: where do we stand?
    Riccardo Autorino
    Department of Urology, Second University, Naples, Italy
    Urol Res 33:460-4. 2005
    ..This selective alpha-blocker should therefore be included in the pharmacological regimen of patients when a conservative approach is considered in the treatment of ureteral lithiasis...